1. Home
  2. VEON vs BLLN Comparison

VEON vs BLLN Comparison

Compare VEON & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VEON Ltd. ADS

VEON

VEON Ltd. ADS

HOLD

Current Price

$52.29

Market Cap

3.8B

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$100.79

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VEON
BLLN
Founded
1992
2016
Country
United Arab Emirates
United States
Employees
N/A
713
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VEON
BLLN
Price
$52.29
$100.79
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$73.40
$126.71
AVG Volume (30 Days)
75.7K
705.8K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.21
$46.29
Revenue Next Year
$1.60
$30.14
P/E Ratio
$6.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.00
$61.96
52 Week High
$64.00
$138.70

Technical Indicators

Market Signals
Indicator
VEON
BLLN
Relative Strength Index (RSI) 49.10 57.19
Support Level $51.66 $79.07
Resistance Level $56.25 $108.50
Average True Range (ATR) 2.25 7.99
MACD -0.55 0.36
Stochastic Oscillator 41.69 67.12

Price Performance

Historical Comparison
VEON
BLLN

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan. Its telecommunications and digital services include voice, fixed broadband, data and cloud services.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: